To elucidate the deregulated functional modules that drive clear cell renal cell carcinoma (ccRCC), we performed comprehensive genomic, epigenomic, transcriptomic, proteomic, and phosphoproteomic characterization of treatment-naive ccRCC and paired normal adjacent tissue samples. Genomic analyses identified a distinct molecular subgroup associated with genomic instability. Integration of proteogenomic measurements uniquely identified protein dysregulation of cellular mechanisms impacted by genomic alterations, including oxidative phosphorylation-related metabolism, protein translation processes, and phospho-signaling modules. To assess the degree of immune infiltration in individual tumors, we identified microenvironment cell signatures tha...
On the basis of multidimensional and comprehensive molecular characterization (including DNA methaly...
In renal cell carcinoma, chromophobe renal cell carcinoma (ChRCC) is a distinct subtype, whose clini...
Clear cell renal cell carcinoma (ccRCC) frequently features a high level of tumor heterogeneity. Elu...
Clear cell renal cell carcinomas (ccRCCs) represent ∼75% of RCC cases and account for most RCC-assoc...
Identifying tumor-cell-specific markers and elucidating their epigenetic regulation and spatial hete...
Human clear cell renal cell carcinoma (ccRCC) is the most common solid lesion within kidney, and its...
Purpose: To explore the tumor proteome of patients diagnosed with localized clear cell renal cancer ...
Genetic changes underlying clear cell renal cell carcinoma (ccRCC) include alterations in genes cont...
Renal cell carcinoma (RCC) is not a single disease, but several histologically defined cancers with ...
Clear cell renal cell carcinoma (ccRCC) is a complex disease with remarkable immune and metabolic he...
Renal cell carcinoma comprises 2 to 3% of malignancies in adults with the most prevalent subtype bei...
Renal cell carcinoma(RCC) is not a single disease, but several histologically defined cancers with d...
The promise of personalized medicine is a therapeutic advance where tumor signatures obtained from d...
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer. The molecules (p...
Abstract Background Renal cell carcinoma (RCC) account for over 80% of renal malignancies. The most ...
On the basis of multidimensional and comprehensive molecular characterization (including DNA methaly...
In renal cell carcinoma, chromophobe renal cell carcinoma (ChRCC) is a distinct subtype, whose clini...
Clear cell renal cell carcinoma (ccRCC) frequently features a high level of tumor heterogeneity. Elu...
Clear cell renal cell carcinomas (ccRCCs) represent ∼75% of RCC cases and account for most RCC-assoc...
Identifying tumor-cell-specific markers and elucidating their epigenetic regulation and spatial hete...
Human clear cell renal cell carcinoma (ccRCC) is the most common solid lesion within kidney, and its...
Purpose: To explore the tumor proteome of patients diagnosed with localized clear cell renal cancer ...
Genetic changes underlying clear cell renal cell carcinoma (ccRCC) include alterations in genes cont...
Renal cell carcinoma (RCC) is not a single disease, but several histologically defined cancers with ...
Clear cell renal cell carcinoma (ccRCC) is a complex disease with remarkable immune and metabolic he...
Renal cell carcinoma comprises 2 to 3% of malignancies in adults with the most prevalent subtype bei...
Renal cell carcinoma(RCC) is not a single disease, but several histologically defined cancers with d...
The promise of personalized medicine is a therapeutic advance where tumor signatures obtained from d...
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer. The molecules (p...
Abstract Background Renal cell carcinoma (RCC) account for over 80% of renal malignancies. The most ...
On the basis of multidimensional and comprehensive molecular characterization (including DNA methaly...
In renal cell carcinoma, chromophobe renal cell carcinoma (ChRCC) is a distinct subtype, whose clini...
Clear cell renal cell carcinoma (ccRCC) frequently features a high level of tumor heterogeneity. Elu...